Company Bellevue Life Sciences Acquisition Corp.
Equities
BLAC
US0791741087
Investment Holding Companies
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.76 USD | +0.33% | 0.00% | +2.19% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Guk-Hyun Hwang
CEO | Chief Executive Officer | 48 | 29/02/20 |
Jin Yoo
DFI | Director of Finance/CFO | 50 | 31/08/21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
In-Chul Chung
BRD | Director/Board Member | 60 | 13/02/23 |
Guk-Hyun Hwang
CEO | Chief Executive Officer | 48 | 29/02/20 |
Jun Chul Whang
BRD | Director/Board Member | 59 | 31/07/20 |
Director/Board Member | 56 | 13/02/23 | |
Jin Park
BRD | Director/Board Member | 56 | 13/02/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 4,041,221 | 1,940,721 ( 48.02 %) | 0 | 48.02 % |
Company contact information
Bellevue Life Sciences Acquisition Corp.
10900 NE 4th Street Suite 2300
98004, Bellevue
+
1st Jan change | Capi. | |
---|---|---|
+2.19% | 60.33M | |
+158.94% | 8.26B | |
+2.33% | 982M | |
+41.91% | 883M | |
+21.01% | 814M | |
+2.01% | 665M | |
+2.33% | 653M | |
-.--% | 600M | |
+7.78% | 525M | |
-.--% | 500M |
- Stock Market
- Equities
- BLAC Stock
- Company Bellevue Life Sciences Acquisition Corp.